Jignesh Patel1, A Agasti1, Satheesh Rao1, Srinivas MG1, Milind Patel2, Prabha Sawant1
Department of Gastroenterology,1
Department of Pathology,2
Lokmanya Tilak Municipal Medical College and Hospital,
Sion, Mumbai – 400022, India
Corresponding Author:
Dr. Jignesh Patel
Email: drjigs2712@gmail.com
DOI:
http://dx.doi.org/
48uep6bbphidvals|450 48uep6bbph|2000F98CTab_Articles|Fulltext Celiac disease predominantly afflicts the proximal small bowel
whereas Crohn’s pathology is most often seen in distal small
bowel and proximal colon. The present case is interesting as
Celiac disease manifested much before Crohn’s disease (CD).
Case report
A 17 year old male presented in 2003 with painless large volume
diarrhea since 5 years without any associated blood, mucus,
tenesmus or steatorrhea. On examination he had short stature,
pallor and secondary sexual characters were absent. Systemic
examination was normal. Laboratory studies showed hemoglobin: 7.6 gm/dl, WBC count: 5600 cells/mm3, neutrophils:
61%, lymphocytes: 33%, platelet count: 417,000/mm3, ESR: 10
mm and MCV:72 fL. RBC morphology on peripheral blood
examination showed predominantly microcytic, hypochromic
red blood cells with anisocytosis, poikilocytosis and target
cells. Stool examination was positive for occult blood and
showed no ova, cyst or fat globules. Renal function tests,
serum bilirubin and liver enzymes were normal. Total protein
was 4.2 gm/dl, and serum albumin was 2.7gm/dl. HIV serology
was negative.Upper GI endoscopy showed decreased
duodenal folds with few nodules. Biopsy from second part of
duodenum showed villous atrophy, crypt hyperplasia with
increased intraepithelial lymphocytes. IgA TTG was 36.74 U
(normal < 10 U). IgA antigliadin antibodies level was 7.8 U
(normal < 2.8 U).Patient was diagnosed with celiac disease and
started on gluten free diet with iron and vitamin supplements.
The patient gained 4 kg weight over next two years and was
symptomatically better with improved hemoglobin. Between
2006 and 2007 he had episodes of intermittent abdominal pain
with diarrhea, weight loss and easy fatigability despite a gluten
free diet. He consulted a local practitioner, and was found to
have severe anemia with a hemoglobin level of 5.5 gm/dl. The
patient also received multiple blood transfusions. In 2008, he
was admitted at our centre for persistent symptoms. He had
significant weight loss with increased frequency and severity
of abdominal pain. On examination he had severe malnutrition
with a BMI of 13.8 kg/m2 and peripheral edema. Investigations
revealed hemoglobin: 5.0 gm/dl, MCV: 60.0 fL, total protein: 3.0
gm/dl, albumin: 1.7 gm/dl. Stool examination was positive for
occult blood, with no fat globules, ova or cyst.Upper GI
endoscopy showed normal duodenal folds. Duodenal biopsy
showed well preserved villi with normal crypt architecture with
no increase in intraepithelial lymphocytes. IgA TTG was at 2.0
U/ml (normal < 7 U/ml). Colonoscopy was normal up till the
terminal ileum. BaMFT showed mild mucosal thickening of
jejunum, with free flow of barium in jejunal and ileal loops.
Push enteroscopy was performed and showed normal jejunal
folds and biopsy from the region showed features of non
specific jejunitis.Capsule endoscopy was performed to
investigate small bowel mucosal morphology which showed
normal proximal jejunal mucosal folds and there were no
ulceration but the capsule got retained in distal jejunum. The
patient was asymptomatic, despite the capsule inside the
intestine for 14 days which did not pass out. CT scan abdomen
showed the capsule in distal jejunum without proximal dilation of bowel loops (Figure 1). The patient was subjected to
exploratory laparotomy. During the surgery the patient was
discovered to have multiple strictures in distal jejunum and
ileum and the capsule was trapped above one of these
strictures. Biopsy of the resected segment showed ulcerated
mucosa with tall villi and intraepithelial lymphocytes. Lamina
propria showed dense inflammatory cells, submucosal edema
with lymphoid follicles, dilated lymphatics and proliferating
nerve bundles. The serosa showed creeping of fat, suggesting
the diagnosis of Crohn’s disease.The patient was started on
azathioprine, was continued on gluten free diet and he gained
weight with improvement in symptoms.

Discussion
Literature showing celiac disease preceding Crohn’s disease
is sparse. In a reported series patients had predominant colonic
CD in association with celiac disease.[1] Our patient presented
with celiac disease much before CD manifested. Five years
after the diagnosis of celiac disease when the disease specific
parameters were negative, the patient experienced episodes of
abdominal pain with weight loss and was investigated to be
diagnosed with jejunal and ileal structuring CD.
Immunopathogenesis of celiac and Crohn’s disease are similar.[2]
Both diseases are mediated by the T-helper type 1(TH1)
pathway[2,3] and are characterized by decreased cellular
apoptosis[4,5,6] which provokes a chronic inflammation
predominantly in the lamina propria accompanied with IL-15
over expression, increased TNFa, interferon ?, and IL-8.[3,7,8,9,10]
Celiac disease is characterized by increased gut permeability due to zonulin reduction[11] and in CD it is related to the action
of TNFa.[12,13,14] It is believed that increased gut permeability in
CD may expose the mucosal immune system to several bacteria
and their antigens mimicking gliadin sequences, resulting in
activation of cytokine networks to initiate a TH1 immunologic
reaction with development of celiac disease lesions. However,
why all CD patients do not develop manifestations of celiac
disease, remains unexplained. Celiac disease has been noted
to have a definitive association with HLA-DQ2 and HLA-DQ8[15]
whereas the relation between CD and HLA genes seems to be
lacking. So, probably only patients with CD having above
haplotypes may develop celiac disease like lesions.
References
- Kitis G, Homes GK, Cooper BT, Thompson H, Allan RN.
Association of celiac disease and inflammatory bowel disease.
Gut. 1980;21:636–41.
- Tursi A , Giorgetti G , Brandimarte G, Elisei W. High prevalence
of celiac disease among patients affected by Crohn’s disease.
Inflamm Bowel Dis. 2005;11:662–6.
- Cominelli F. Cytokine-based therapies for Crohn’s disease—new
paradigms. N Engl J Med. 2004;351:2045–8.
- Levine AD, Fiocchi C. Regulation of life and death in lamina
propria cells. Immunology. 2001;13:195–9.
- Itoh J, de La Motte C, Strong SA, Levine AD, Fiocchi C. Decreased
Bax expression by mucosal T cells favours resistance to apoptosis
in Crohn’s disease. Gut. 2001;49:35–41.
- Chernavsky AC, Rubio AE, Vanzulli S, Rubinstein N, de Rosa S,
Fainboim L. Evidences of the involvement of Bak, a member of
the Bcl-2 family proteins, in active coeliac disease. Autoimmunity.
2002;35:29–37.
- Liu Z, Geboes K, Colpaert S, D’haens GR, Rutgeers P, Ceuppens
JL. IL-15 is highly expressed in inflammatory bowel disease and
regulates local T cell-dependent cytokine production. J Immunol.
2000;164:3608–15.
- Maiuri L, Ciacci C, Vacca L, Ricciardielli I, Auricchio S,
Quarantino S, et al. IL-15 drives the specific migration of CD94+
and TCR- gammadelta+ intraepithelial lymphocytes in organ cultures of treated celiac patients. Am J Gastroenterol.
2001;96:150–6.
- Meresse B, Chen Z, Ciszewski C, Tretiakova M, Bhagat G,
Krausz TN, et al. Coordinated induction by IL15 of a TCRindependent
NKG2D signaling pathway converts CTL into
lymphokine-activated killer cells in celiac disease. Immunity.
2004;21:357–66.
- Jelinkova L, Tuckova L, Cinova J, Flegelova Z, Tlaskalova-
Hogenova H. Gliadin stimulates human monocytes to production
of IL-8 and TNF-alpha through a mechanism involving NFkappaB.
FEBS Lett. 2004;571: 81–5.
- Fasano A, Not T, Wang W, Uzzau S, Berti I, Tommasini A, et al.
Zonulin, newly discovered modulator of intestinal permeability,
and its expression in coeliac disease. Lancet. 2000;335:1518–9.
- Tursi A. Delayed orocecal transit time and bacterial overgrowth
Crohn’s disease. J Clin Gastroenterol. 2001;32:274–5.
- Yap LM, Ahmad T, Jewell DP. The contribution of HLA genes
to IBD susceptibility and phenotype. Best Pract Res Clin
Gastroenterol. 2004;18:577–96.
- Gibson PR. Increased gut permeability in Crohn’s disease: is
TNF the link? Gut. 2004;53:1724–5.
- Tursi A. The genetic puzzle of celiac disease. Gastroenterology.
2004;126:1216–7.
|